precision medicine

Immunotherapy for Lung Cancer

Immunotherapy for Lung Cancer

Posted by  | precision medicine, treatment

It’s lung cancer awareness month. Hear lung cancer expert Julie Brahmer and cancer genetics expert Victor Velculescu explain how immunotherapy is becoming a game changer for certain patients. Learn about the latest advances from our Bloomberg~Kimmel Institute for Cancer Immunotherapy and how we are helping patients with lung cancer live better and longer. Watch the(...)

‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle

‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle

Posted by  | precision medicine

*Update Aug. 30, 2017 - The FDA has approved the CAR-T therapy tisagenlecleucel for certain leukemia patients. News of an FDA advisory committee that has reviewed one pharmaceutical company's approach to engineering a cancer patient's own T-cells, the so-called soldiers of the immune system, and injecting them back into patients with astounding success has prompted questions(...)

A Conversation about Cancer

A Conversation about Cancer

Posted by  | precision medicine, Prevention/Screening, Research, Uncategorized

On Nov. 3, 2015, a capacity crowd of more than 250 Johns Hopkins leaders, faculty, staff, students, donors, and other guests filled the Albert H. Owens Auditorium at the Johns Hopkins Kimmel Cancer Center to honor the philanthropy of Sidney Kimmel for advancing cancer discovery and care. Hundreds more watched via video streaming as Kimmel(...)

Gene Patents Get Supreme Decision

Posted by  | precision medicine

Last week's U.S. Supreme Court decision on Myriad's breast cancer gene patents sparked many comments from patients, the public and scientists. Here's what several Johns Hopkins experts had to say about the topic: "I am thrilled with the Supreme Court's unanimous decision to overturn gene patents.  This was the only choice and will open up(...)

Waiting Room Observations

Posted by  | precision medicine

Over the last thirty years, about every decade I’ve found myself in a cancer center waiting room--first in 1984 with my husband, in 1999 with my father, and now this year with my mother.  Last week, I accompanied my mother on her regular visit.  It was a busy day in the clinic, and as I(...)

Lung Cancer: Still the Top Cancer Killer

Posted by  | precision medicine, treatment

Recent news of the full results of the National Lung Screening Trial (NLST) published in the New England Journal of Medicine underscores the heavy toll that lung cancer takes on many lives.  It's still the deadliest of all cancers.  For Phyllis Curtis, who had enrolled in the trial at Johns Hopkins, the trial and screening(...)

Avastin: Good Drug, Bad Decision?

Posted by  | precision medicine, treatment

Recent news that the FDA will not approve the use of the drug Avastin for breast cancer has many patients who have benefitted questioning why.  Kimmel Cancer Center director William Nelson believes it is a perfect example of why personalized cancer medicine—getting the right drugs to the right patients—is so important. “Often in trials, drugs(...)